MOTS-C Mitochondrial Peptide Research Protocol Design
In published preclinical research examining MOTS-c, study designs have focused on metabolic function characterization in cell culture and rodent models, with particular attention to AMPK pathway activation and mitochondrial-nuclear communication. The research literature originating from Lee and colleagues at USC documents original characterization of MOTS-c nuclear translocation and AMPK activation, with subsequent published work expanding into metabolic, aging, and exercise physiology models. Researchers designing MOTS-c studies typically reference these foundational publications for established protocol parameters.
Research Reference Only: This page documents how research protocols appear in published scientific literature. All content is for in vitro research reference only and does not constitute guidance for human use or experimentation.
Study Design Types in Published Literature
How published researchers have structured studies in this research area.
AMPK Activation and Pathway Studies
Published cell culture and animal research has characterized MOTS-c AMPK activation using phospho-specific Western blotting and downstream pathway measurements. Study designs expose cell cultures or animal subjects to MOTS-c and measure phospho-AMPK, phospho-ACC, and metabolic gene expression as primary endpoint indicators.
Common Endpoints
- •Phospho-AMPK (pT172) Western blot
- •Phospho-ACC (fatty acid oxidation marker)
- •GLUT4 expression and translocation
- •PGC-1alpha gene expression
Nuclear Translocation Studies
Original published research by Lee and colleagues characterized MOTS-c nuclear translocation using subcellular fractionation and fluorescent tagging approaches. Study designs expose cells to metabolic stress (nutrient deprivation, AICAR) and characterize mitochondrial versus nuclear MOTS-c distribution by fractionation and immunofluorescence.
Common Endpoints
- •Subcellular fractionation MOTS-c detection
- •Confocal immunofluorescence localization
- •Nuclear MOTS-c binding partner identification
- •Stress-dependent translocation quantification
Metabolic Function Studies in Rodent Models
Published metabolic research has examined MOTS-c in high-fat diet and aged rodent models using glucose tolerance testing, insulin tolerance testing, and indirect calorimetry. Study designs document dose and frequency of MOTS-c administration alongside metabolic outcome endpoint measurement schedules.
Common Endpoints
- •Glucose tolerance test (GTT)
- •Insulin tolerance test (ITT)
- •Body composition (DEXA)
- •Indirect calorimetry (RER, VO2)
Exercise Physiology Research Models
Published exercise physiology research has characterized MOTS-c as an exercise-responsive mitokine. Study designs measure circulating MOTS-c levels in response to exercise protocols in animal models and characterize whether exogenous MOTS-c recapitulates aspects of exercise-induced metabolic adaptation in sedentary animal cohorts.
Common Endpoints
- •Circulating MOTS-c measurement (ELISA)
- •Exercise capacity testing (treadmill, rotarod)
- •Mitochondrial biogenesis markers
- •Metabolic gene expression post-exercise
Values from Published Preclinical Literature
Parameters documented in published research. These are literature values from specific model systems, not recommendations.
| Parameter | Published Value | Source |
|---|---|---|
| Cell Culture Concentration in Published Studies | 1 to 10 micromolar in published MOTS-c cell culture research from Lee group | Lee et al. published MOTS-c cell biology research |
| In Vivo Dose in Published Rodent Metabolic Studies | 0.5 to 15 mg per kg body weight in published rodent metabolic research | Published MOTS-c metabolic and aging rodent research |
| Administration Route in Published Animal Studies | Intraperitoneal injection in the majority of published preclinical MOTS-c studies | Published MOTS-c preclinical methodology sections |
| Treatment Duration in Published Metabolic Studies | 1 to 8 weeks in published metabolic dysfunction rodent model studies | Published MOTS-c metabolic research literature |
| Metabolic Endpoint Schedule | GTT performed after 8 to 12 hour fast at baseline and 4-week intervals in published protocols | Standard published metabolic phenotyping methodology |
Research Considerations in Published Protocols
- 1
MOTS-c plasma measurement requires validated ELISA with adequate sensitivity; published methodology sections document matrix effects and standard curve parameters
- 2
Subcellular fractionation quality assessment through organelle marker Western blotting is documented as a standard quality control in published MOTS-c nuclear translocation studies
- 3
Metabolic phenotyping studies in published MOTS-c research use 4 to 5-hour fasting for GTT to standardize baseline glucose status across all animal subjects
- 4
Published exercise studies document circadian timing of exercise and MOTS-c measurement as relevant variables affecting observed MOTS-c levels in published animal research
- 5
High-fat diet model studies in published MOTS-c research use 60% kcal fat diets for 8 to 12 weeks to establish metabolic dysfunction before treatment intervention
Related Research
Frequently Asked Questions
Source Research Compounds
Spartan Peptides supplies research-grade compounds at least 98% HPLC-verified purity with Certificate of Analysis documentation. Domestic US supply, same-day dispatch before 2 PM.
For in vitro research use only. Not for human consumption or experimentation.